MedPath

A High School Program for Preventing Prescription Drug Abuse

Not Applicable
Conditions
Prescription Drug Abuse (Not Dependent)
Substance Abuse
Substance Use
Interventions
Behavioral: LST High School Online
Registration Number
NCT03219190
Lead Sponsor
National Health Promotion Associates, Inc.
Brief Summary

This project will develop and evaluate a program to prevent prescription drug abuse in high school students

Detailed Description

This Fast-Track SBIR project is designed to address the critical need for an effective primary prevention approach for prescription drug abuse (PDA), an urgent public health crisis in the United States. The project involves developing and testing an innovative new approach to the primary prevention of PDA among high school students utilizing e-learning and small group facilitator-led intervention modalities. The intervention is an adaptation of the evidence-based substance abuse prevention approach called Life Skills Training (LST). The adapted intervention will address the relationship between PDA and alcohol, tobacco and other drug (ATOD) use and abuse; positively change social norms surrounding ATOD and PDA; discourage diversion of prescription medications; enhance protective factors by building social and self-regulation skills through interactive learning and behavioral rehearsal scenarios.

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
3000
Inclusion Criteria
  • High school aged-youth
Exclusion Criteria
  • Significant cognitive impairment or severe learning disabilities, as screened by field staff at participating sites

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
LST High School OnlineLST High School OnlineProvided with the prevention program, consisting of e-learning modules and classroom sessions.
Primary Outcome Measures
NameTimeMethod
Change in any prescription drug use in the past yearPost-test (within 2 weeks of completing final session/module of the intervention), 12-month follow-up, 24-month follow-up

The investigators will assess (via questionnaire) key study variables regarding prescription drug abuse and hypothesized risk and protective factors. These outcomes will be examined and compared in both the intervention group and the control group at a post-test assessment and 6- and 12-month follow-up assessments.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

National Health Promotion Associates

🇺🇸

White Plains, New York, United States

© Copyright 2025. All Rights Reserved by MedPath